In conclusion, our findings suggest that leptin, through its effects on H3K27 epigenetic changes, plays a pivotal role in regulating CCL2/MCP‐1 expression in ASCs, revealing a novel mechanism by which leptin may contribute to WAT inflammation and the pathophysiology of obesity. The gene discussed is CCL2; the disease is obesity disorder.